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Abstract: Response mechanisms to external stress rely on networks of proteins able to activate specific
signaling pathways to ensure the maintenance of cell proteostasis. Many of the proteins mediating
this kind of response contain intrinsically disordered regions, which lack a defined structure, but still
are able to interact with a wide range of clients that modulate the protein function. Some of these
interactions are mediated by specific short sequences embedded in the longer disordered regions.
Because the physicochemical properties that promote functional and abnormal interactions are similar,
it has been shown that, in globular proteins, aggregation-prone and binding regions tend to overlap.
It could be that the same principle applies for disordered protein regions. In this context, we show
here that a predicted low-complexity interacting region in the disordered C-terminus of the stress
response master regulator heat shock factor 1 (Hsf1) protein corresponds to a cryptic amyloid region
able to self-assemble into fibrillary structures resembling those found in neurodegenerative disorders.
Keywords: amyloid; Hsf1; protein aggregation; intrinsically disordered regions; Q/N-rich regions;
low complexity; molecular recognition features
1. Introduction
Eukaryotic cells have the capacity to overcome detrimental environmental conditions, such
as hyperthermia or oxidative stress. This ability to maintain a balanced proteostasis depends on
a restricted group of polypeptides, named heat shock proteins (HSPs) [1,2]. This set of protective
proteins are designed to guarantee protein solubility and impede a massive loss of protein function
due to degradation, post-transcriptional modifications, or aggregation. In this context, heat shock
factor 1 (Hsf1) has been classically considered as the master orchestrator of this finely tuned
response [3]. Hsf1 is an inducible transcription factor that, after activation, leads to the transcription
of several HSPs and the subsequent metabolic readjustment [4]. Generically, in order to execute
its function, Hsf1 undergoes trimerization, nuclear specific localization, and an extensive range of
post-transcriptional modifications [2]. Indeed, under basal conditions, the protein is subjected to a
negative regulation loop in which intramolecular contacts and specific interactions with other HSPs
such as HSP90 preserve the inactive monomeric form of the protein [2,5,6].
Hsf1 function is conserved among different species, the DNA binding domain (DBD) being the
most conserved region in the protein sequence. Despite the fact that the DBD corresponds to a folded
domain, Hsf1 is thought to be mostly unstructured [7]. In fact, it is well-established that numerous
proteins related with DNA-binding and transcriptional regulation lack ordered tertiary structure or
contain long disordered segments under physiological conditions [8,9]. In these proteins, disordered
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regions contribute to their conformational plasticity and client promiscuity and this is crucial to
establish a wide range of specific interactions [10]. In many cases, these interactions seem to depend on
the existence of short sequence motifs which may or may/not undergo a disorder to order transition
upon binding [11–14]. In addition, it is becoming increasingly evident that the compositional bias of
certain disordered low complexity regions is an important determinant of protein–protein interactions
in transcription factors [15].
It has been shown that the physicochemical properties behind functional protein–protein
interactions overlap significantly with those accounting for the anomalous interactions leading
to protein aggregation [16]. As a result, interaction sites in protein complexes [17,18], as well as
the interfaces of homomeric and heteromeric globular proteins, display significant amyloidogenic
propensity [19,20]. This implies that exposed aggregation-prone regions cannot be totally purged out
by evolution from the sequences of globular proteins, because they are needed for binding and/or
functional assembly [18,19]. One question is whether in disordered proteins, where the bulk of the
sequence is exposed to solvent, this duality between the establishment of functional and deleterious
interactions also occurs. It is shown here that, in yeast Hsf1, a disordered and low complexity region at
the C-terminus of this transcription factor is predicted to act in molecular recognition, at the cost of
aggregating spontaneously into ordered amyloid assemblies.
2. Results
2.1. Identification of a Cryptic Amyloid Sequence Inside a Disordered and Low Complexity Region in Hsf1
The order/disorder content of yeast Hsf1 was studied. First, the locations of constituent functional
domains and unstructured regions in the full-length protein were examined (Figure 1). PFAM indicates
that yeast Hsf1 contains a single annotated functional domain comprising residues 175–275, which
correspond to the HSF_DNA-binding domain [21]. This domain is highly conserved both structurally
and sequentially from yeast to humans and binds to specific DNA regulatory regions involved in
the modulation of the complex HSF transcriptional activity [2]. Thus, according to PFAM, less
than 15% of Hsf1 residues are implicated in the formation of functional folded moieties in the
monomeric state. Indeed, the N-terminal Hsf1 1–167 region has been experimentally shown to
lack any regular structure [22]. This is consistent with the predictions of protein disorder provided
by two different algorithms, ESpritz-NMR [23] and IUPred [24], which point out that the protein
regions at the two sides of the HSF_DNA-binding domain are essentially disordered (Figure 1).
The SEG algorithm [25] indicates that Hsf1-disordered regions contain several short low complexity
segments (Figure 1). We used FELLS [26] to determine if any of these low complexity regions displayed
compositional bias. Interestingly enough, the region comprising residues 493–527 exhibits a striking
compositional bias, with an overall asparagine content of 40% (Figure 1). Notably, this is an N
enrichment comparable to that observed in the prion domains of several yeast prions [27,28]. In yeast,
these glutamine/asparagine (Q/N)-rich domains promote self-assembling interactions, which result
in conformational conversion [29] and phase separation [30].
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Figure 1. The cryptic amyloid core of heat shock factor 1 protein (Hsf1) in Saccharomyces cerevisiae (S. 
cerevisiae). Hsf1 diagram showing the location of the identified Pfam domain (grey), predicted 
disordered regions (orange), low complexity segments (violet), glutamine/asparagine (Q/N)-rich 
regions (blue), protein binding sites (green), and the cryptic amyloid core (red). The sequence of the 
amyloid core is shown in the red box. Hsf1: heat shock protein 1. 
We have recently shown that the disordered, low complexity, Q/N-rich regions of yeast prions 
and other prion-like proteins might contain cryptic amyloidogenic regions that can contribute 
significantly to trigger protein assembly [31–33]. These regions differ from the classical amyloid cores 
found in pathogenic proteins in that they are longer and more polar, in such a way that the amyloid 
potential is less concentrated, allowing the protein to remain in a soluble state under most 
physiological conditions, while still keeping a certain amyloid propensity that might facilitate its 
assembly in certain circumstances [34]. We analyzed whether the disordered and N-rich Hsf1 region 
493–527 hid an amylogenic stretch using WALTZ, an algorithm that exploits a position-specific 
scoring matrix to identify potential amyloid sequences [35]. WALTZ predicted the 504-
INDIIFNTNLANNLSNYN-521 sequence as the longest region displaying significant amyloid 
potential. It is worth mentioning that, in this segment, 55% of the residues have a polar nature and 
accordingly, the hydropathicity is much lower than that of the typical amyloid cores found in disease-
linked proteins (Table 1). This explains why well-validated aggregation predictors like Aggrescan 
[36] and Zyggregator [37], which consider sequence hydrophobicity as a major contributor to protein 
aggregation, did not detect any aggregation-prone regions in Hsf1 sequence 493–527. 
Here, it was investigated whether our candidate amyloid core could potentially be a region 
involved in the establishment of intermolecular contacts. To this end, ANCHOR [38] and 
DisoRDPbind [39] were used, which are two conceptually different algorithms that aimed to identify 
protein binding sequences in disorder proteins or regions. Interestingly enough, both programs 
successfully identified the sequence stretch around Hsf1 residues 504–521 as a potential protein 
binding region (Figure 1). 
Overall, the bioinformatics analysis suggest that Hsf1 might contain a functional amyloid core 
embedded in a disordered and low complexity region. To confirm that this soluble transcription 
factor bears a sequence with the potential to form amyloid-like assemblies, the 18-residue-long 
peptide was synthesized and characterized experimentally. 
  
Figure 1. The cryptic amyloid core of heat shock factor 1 protein (Hsf1) in Saccharomyces cerevisiae
(S. cerevisiae). Hsf1 diagram showing the location of the identified Pfam domain (grey), predicted
disordered regions (orange), low complexity segments (violet), glutamine/asparagine (Q/N)-rich
regions (blue), protein binding sites (green), and the cryptic amyloid core (red). The sequence of the
amyloid core is shown in the red box. Hsf1: heat shock protein 1.
We have recently shown that the disordered, low complexity, Q/N-rich regions of yeast prions and
other prion-like proteins might contain cryptic amyloidogenic regions that can contribute significantly
to trigger protein assembly [31–33]. These regions differ from the classical amyloid cores found in
pathogenic proteins in that they are longer and more polar, in such a way that the amyloid potential
is less concentrated, allo ing the protein to remain in a soluble state under ost physiological
conditions, while still keeping a certain amyloid propensity that might facilitate its assembly in certain
circumstances [34]. We analyzed whether the disordered and N-rich Hsf1 region 493–527 hid an
amylo enic stretch using WALTZ, an algorithm that exploits a position-specific scoring matrix to
identify potential amyloid sequences [35]. WALTZ predicted the 504-INDIIFNTNLANNLSNYN-521
sequence as the longest region displaying significant amyloid potential. It is w rth mentio ing
that, in this segment, 55% of the residues have a polar nature and ccordingly, the hydropathicity
is much l wer th n that of th typ cal amyloid cores found in disease-linked prot ins (Table 1).
This explains why well-validated aggr gation pr dictors like Aggrescan [36] a d Zyggregat r [37],
which consider sequence hydrophobicity as a majo contributor to protei aggregation, did not detect
any agg ga ion-pron re ions in Hsf1 sequence 493–527.
H re, t was investigated whether our candidate amyloid core could potentially be a region involved
in the esta lishment of intermolecular contacts. To this end, ANCHOR [38] and DisoRDPbind [39] were
used, which are two co ceptually different algorithms that aimed to ide tify pr tein binding sequences
in disorder prot ins or regions. Interestingly enough, both programs uccessfully identifi d the sequ ce
stretch around Hsf1 residues 504–521 as a potential protein binding region (Figure 1).
verall, the bioinfor atics analysis suggest that Hsf1 might contain a functional amyloid core
e bedded in a disordered and low complexity region. To confirm that this soluble transcription factor
bears a sequence with the potential to form amyloid-like assemblies, the 18-residue-long peptide was
synthesized and characterized experimentally.
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Table 1. Amyloid core hydropathicity of Hsf1 in S. cerevisiae. The GRAVY score (average hydrophobicity
and hydrophilicity) was evaluated using the EXPASY ProtParam tool [40]. The GRAVY scores for the
amyloid cores of α-synuclein (ASYN) and Aβ42, involved in Parkinson’s and Alzheimer’s disease,
respectively, are shown for comparison.
Protein Amyloid Core Gravy Score
Hsf1 INDIIFNTNLANNLSNYN −0.283
ASYN
GVLYVG 1.683
GGAVVTGVTAVAQ 1.238
Aβ42
GAIIGLMVGGVVI 2.462
QKLVFFAE 0.562
2.2. The Amyloid Core of Hsf1 Assembles into β-Sheet Enriched Aggregates
As a first step, and in order to determine whether the candidate peptide has the ability to aggregate
in vitro, Hsf1 amyloid core peptide samples were prepared at 25, 50, and 100 µM and incubated at
25 ◦C for 120 h. Aggregation was systematically monitored by measuring changes in synchronous
light scattering [41]. As shown in Figure 2A, a concentration-dependent scattering signal could be
observed, reaching a maximum at 100 µM of peptide. These data indicate that despite the candidate
amyloid core is clearly less hydrophobic than those in classic amyloids, it can still establish the initial
intermolecular interactions that lead to the buildup of high-order assemblies.
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concentrations. 
Next, we explored the presence of exposed hydrophobic clusters in the formed peptide 
aggregates by measuring their binding to 4,4-bis-1-anilinonaphthalene-8-sufonate (Bis-ANS), a dye 
that exhibits fluorescence enhancement upon interaction with exposed hydrophobic surfaces as well 
as a blue shift of the peak maximum [42,43] (Figure 2B). We found complete agreement between the 
Bis-ANS and the light-scattering assays. The Bis-ANS fluorescence presents a concentration-
dependent intensity increase and the maximum emission shifts from 521 nm (in the presence of 25 
µM of peptide) to 505 nm at 100 µM. These spectral changes indicate that the peptide aggregation 
results in the formation of novel/larger hydrophobic patches, thus suggesting that the interactions 
between the peptide hydrophobic residues lead to its assembly. 
To analyze the secondary structure content of the Hsf1 peptide aggregates, the amide I region 
of the Fourier Trasform Infrared (FT-IR) spectrum (1700–1600 cm−1) upon its incubation at 100 µM for 
120 h was recorded. Deconvolution of the obtained spectra allow us to identify a strong band at 1628 
cm−1, which is indicative of a predominance of extended intermolecular β-sheet structures. This signal 
is the largest contributor to the absorbance spectrum, accounting for 62% of the total area. The other 
Figure 2. Aggregation of the soft amyloid core in Hsf1 as a function of the concentration.
Aggregation (A) and the formation of hydrophobic surfaces (B) were monitored by light scattering
and 4,4-bis-1-anilinonaphthalene-8-sufonate (Bis-ANS) fluorescence emission, respectively, at various
peptide concentrations.
Next, we explored the presence of exposed hydrophobic clusters in the formed peptide aggregates
by measuring their binding to 4,4-bis-1-anilinonaphthalene-8-sufonate (Bis-ANS), a dye that exhibits
fluorescence enhancement upon interaction with exposed hydrophobic surfaces as well as a blue shift
of the peak maximum [42,43] (Figure 2B). We found complete agreement between the Bis-ANS and
the light-scattering assays. The Bis-ANS fluorescence presents a concentration-dependent intensity
increase and the maximum emission shifts from 521 nm (in the presence of 25 µM of peptide) to
505 nm at 100 µM. These spectral changes indicate that the peptide aggregation results in the formation
of novel/larger hydrophobic patches, thus suggesting that the interactions between the peptide
hydrophobic residues lead to its assembly.
To analyze the secondary structure content of the Hsf1 peptide aggregates, the amide I region
of the Fourier Trasform Infrared (FT-IR) spectrum (1700–1600 cm−1) upon its incubation at 100 µM
for 120 h was recorded. Deconvolution of the obtained spectra allow us to identify a strong band
Int. J. Mol. Sci. 2018, 19, 1384 5 of 13
at 1628 cm−1, which is indicative of a predominance of extended intermolecular β-sheet structures.
This signal is the largest contributor to the absorbance spectrum, accounting for 62% of the total area.
The other detected peak at 1667 cm−1 is attributable to the presence of β-turns (Figure 3). Because no
anti-parallel β-sheet band was detected at ~1690 cm−1, a preferential parallel β-sheet organization for
the self-assembled peptide is suggested.
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maximum. We analyzed CR binding to the aggregated peptide at 25, 50, and 100 µM. As expected, 
the peptide at 100 µM promoted the maximum shift in the CR spectra from 497 nm, in the absence of 
peptide, to 515 nm (Figure 4A). 
Similarly, binding of ThT to the Hsf1 amyloid core peptide induced a large enhancement in the 
intensity of ThT fluorescence emission relative to the free dye, increasing as a function of the peptide 
concentration (Figure 4B). Additionally, binding of ThS to 100 µM peptide aggregate was tested by 
fluorescence microscopy. Areas rich in fibrous material appear stained with ThS, giving a bright green-
yellow fluorescence against a dark background (Figure 4C). Overall, the results reported from the dye 
staining experiments strongly suggest an amyloid-like organization of the peptide in the aggregates. 
Figure 3. Amyloid core secondary structure of Hsf1. The secondary structure was determined from
the Attenuated Total Reflectance (ATR) Fourier Transform Infrared (FT-IR) absorbance spectrum in
the amide I region. The red line cor esponds to the original spectrum; the blue area indicates the
contribution of the inter-molecular β-she t signal to the total area upon Gaus ian deconvolution.
Collectively, the data indicate that the predicted amyloid core of Hsf1 spontaneously
self-assembles into highly ordered supramolecular structures highly enriched in β-sheet content.
2.3. Hsf1 Amyloid Core Forms Amyloid-Like Fibrillary Structures
Next, to assess whether the detected β-sheets structures in Hsf1 peptide aggregates correspond
to amyloid-like assemblies, the amyloid-specific dyes Congo red (CR), Thioflavin-T (ThT) and
Thioflavin-S (ThS) ere used [44]. CR is widely used for the detection of amyloid material [45];
when the dye is bound to cross β-sheet structures there is hypercromicity and a red shift of the
absorbance maximum. We analyzed CR binding to the aggregated peptide at 25, 50, and 100 µM.
As expected, the peptide at 100 µM promoted the maximum shift in the CR spectra from 497 nm, in the
absence of peptide, to 515 nm (Figure 4A).
Similarly, binding of ThT to the sf1 a yloid core peptide induced a large enhancement in
the intensity of ThT fluorescence emission relative to the free dye, increasing as a function of the
peptide concentration (Figure 4B). Additionally, binding of ThS to 100 µM peptide aggregate was
tested by fluorescence microscopy. Areas rich in fibrous material appear stained with ThS, giving a
bright green-yellow fluorescence against a dark background (Figure 4C). Overall, the results reported
from the dye staining experiments strongly suggest an amyloid-like organization of the peptide in
the aggregates.
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by phase contrast and fluorescence microscopy displaying the green fluorescence characteristic of 
amyloid structures. 
To check whether the peptide assemblies could have any internal fibrillar structure, we 
performed a morphological analysis using transmission electron microscopy (TEM) (Figure 5). In 
agreement with the above reported results, the 100 µM Hsf1 amyloid core peptide solution self-
assembles, forming fibrillar arrangements after 120 h incubation at 25 °C. The resultant fibrils are 
straight, unbranched, and exhibit a diameter that varies from 6 to 12 nm, being thus similar to the 
fibrillar structures formed by amyloidogenic proteins involved in neurodegenerative disorders [46]. 
Figure 4. Binding of amyloid dyes to the cryptic amyloid core of Hsf1. (A) Congo red (CR) spectral
changes in the presence of Hsf1 peptide incubated at various concentrations during 120 h at 25 ◦C;
note the characteristic shift from 497 nm to 515 nm when the dye is bound to amyloid-like aggregates;
(B) changes in the fluorescence emission spectrum of Thioflavin-T (Th-T) when excited at 440 nm
upon binding to the aggregated peptide at various concentrations after 120 h incubation at 25 ◦C;
(C) Thioflavin-S fluorescence of stained aggregated amyloid material of Hsf1 at 100 µM in Phosphate
buffered saline (PBS) buffer after 120 h incubation at 25 ◦C. Images were obtained at 40× magnification
by phase contrast and fluorescence microscopy displaying the green fluorescence characteristic of
amyloid structures.
o check whether the peptide assemblies could have any inter al fibrillar structure, we performed
a morphological analysis using transmission electron microscopy (TEM) (Figure 5). In agreement with
the above reported results, the 100 µM Hsf1 amyloid core peptide solution self-assembles, forming
fibrillar arrangements after 120 h incubation at 25 ◦C. The resultant fibrils are straight, unbranched,
and exhibit a diameter that varies from 6 to 12 nm, being thus similar to the fibrillar structures formed
by amyloidogenic proteins involved in neurodegenerative disorders [46].
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Figure 5. Fibrillar structure of Hsf1 cryptic amyloid core. Representative electron micrographs of Hsf1
aggregated peptide at 100 µM in PBS after 120 h of incubation at 25 ◦C.
2.4. Hsf1 Amyloid Core Self-Assembles Very Fast
While the classical predictors suggested a low amyloid propensity for the Hsf1 peptide, the above
data indicate the contrary. To assess if the aggregation tendency of the peptide was high enough to
promote its immediate assembly, the properties of the solution upon peptide dilution at 100 µM in
Phosphate buffered saline (PBS) (time 0 h) were monitored, and compared with those of the final
aggregates (120 h). Synchronous light scattering indicated an initial level of aggregated material similar
to that observed at the end point of the reaction (Figure 6A). However, the conformational properties
of early and late aggregates are significantly different. Early aggregates display a higher Bis-ANS
signal (Figure 6B); in contrast, they exhibit much lower ThT binding than late aggregates (Figure 6C).
This observation is consistent with their less ordered architecture as assessed by TEM images, which
show the presence of proto-fibrillar assemblies that tend to coalescence in larger aggregates (Figure 6D).
Altogether, the data indicate that the Hsf1 amyloid core undergoes a very fast aggregation reaction
into proto-fibrils with exposed hydrophobic patches and a low average content of amyloid-like regions.
The evolution of these aggregates into the typical amyloid assemblies observed at the end of the
reaction necessarily involves the burial of a fraction of previously exposed hydrophobic residues
inside the ordered fibrils. These data corroborate the strong aggregation propensity of the identified
disordered region of Hsf1.
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3. iscussion
The present ork exe plifies a strategy to uncover hidden a yloid seg ents in the disordered
regions of proteins. Together, the co putational and biophysical analyses provide evidence for the
existence of a cryptic a yloid core e bedded in a disordered and lo co plexity region of yeast
sf1. A peptide corresponding to this region spontaneously self-asse bles into CR- and ThT-positive
β-sheet enriched a yloid fibrils in vitro.
hile hydrophobic interactions seem to be important for the assembly, the majority of the
residues in the amyloid core have a polar nature, which endorses this segment with an overall lo er
hydrophobicity than the cores in pathogenic amyloids. Indeed, 70% of the polar residues in this
region correspond to asparagine, a composition that is reminiscent of that found in the amyloidogenic
regions of prion-like domains, which contribute significantly to their conformational conversion [28,31].
While in the light of the extensive literature on Hsf1 it is unlikely that in vivo and in the context of
the full-length protein this region would drive Hsf1 amyloid formation, it is now evident that protein
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evolution tends to purge out aggregation-prone regions if they do not serve functional purposes,
especially if they are constantly exposed to solvent, as occurs in disordered protein regions [47]. In fact,
in contrast to classical pathogenic amyloids, when amyloid sequences occur in disordered regions,
their aggregation potential tends to be less concentrated, thus precluding uncontrolled aggregation and
suggesting they might play instead a functional role [33]. Indeed, ANCHOR [38] and DisoRDPbind [39]
predictions converge to suggest that the cryptic amyloid core we identified in Hsf1 might correspond
to a molecular recognition element [48]. If this comes to be true, it would imply that both in the context
of folded and disordered proteins the determinants for functional and deleterious interactions tend to
overlap. Indeed, a number of diseases that have been associated with disorder-containing proteins
seem to be caused by undesirable protein interactions [49].
This work contributes new data in favor of the hypothesis that protein aggregation-prone regions
might play a role in protein–protein interactions [50]; thus supporting the vision that, despite the
medical relevance of pathogenic amyloid formation, this deleterious reaction constitutes only one of
the many different aggregation-driven phenomena that might occur in a cell [51].
It is evident that more work is needed to confirm the suggested relationship between binding
and amyloid propensities in the context of Hsf1. However, the fact that the properties of the identified
amylogenic segment coincide precisely with those of the amyloid core we found previously in
the prion-like domain of the bacterial transcription terminator Rho [52,53], which was afterwards
confirmed to self-assemble in vivo through this specific region in order to regulate its activity [54],
indicates that a deeper characterization of Hsf1 conformational and self-assembling properties will be
worth the effort.
4. Materials and Methods
4.1. Materials
The 18-residue peptide with the sequence INDIIFNTNLANNLSNYN, that corresponds to
the predicted soft amyloid core of S. cerevisiae Hsf1, was purchased from CASLO ApS (Scion
Denmark Technical University, Copenhagen, Denmark) and used without further purification.
Other chemicals reagents and buffers were purchased from Sigma-Aldrich (Sigma Aldrich, Merck
KGaA, Darmstadt, Germany).
4.2. Computational Identification of Hsf1 Soft Amyloid Cores in Low Complexity Regions
The sequence of Saccharomyces cerevisiae (S. cerevisiae) Hsf1 (P10961) was downloaded from
Uniprot [55]. It was first scanned for the presence of regions with a compositional bias with at least
30% of Q/Ns inside intrinsically disordered regions using FELLS [26] and IUPred algorithms [24,35].
The identified region (493–527), was further evaluated in a search for soft amyloid cores with
WALTZ [35], which resulted in the identification of one positive candidate region. A search for a protein
binding region within this soft amyloid core was performed using ANCHOR [38] and DisoRDPbind [39],
resulting in the identification of the Hsf1 soft amyloid core as a putative protein binding region.
4.3. Hsf1 Soft Amyloid Core Peptide Preparation
The peptide was initially resuspended in 1,1,1,3,3,3-hexafluoropropanol to remove any residual
aggregate and afterwards the solvent was evaporated under vacuum. The peptide stock solution was
prepared solubilizing the resulting peptide film at a final concentration of 5 mM in 100% dimethyl
sulfoxide and stored at −80 ◦C. Before each analysis, the sample was diluted to 150 µM in PBS pH 7.4.
For aggregation assays the peptide was diluted to 25, 50, and 100 µM and incubated for 120 h at 25 ◦C.
4.4. Synchronous Light Scattering
Synchronous light scattering was monitored using a Cary Eclipse spectrofluorometer (Varian,
Palo Alto, CA, USA). Spectra were recorded as the accumulation of three consecutive scans and the
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conditions of the acquisition were: excitation wavelength of 360 nm, emission range from 340 to 380 nm,
and slit widths of 5 nm at 25 ◦C in PBS pH 7.4 buffer. The samples were sonicated for 10 min in an
ultrasonic bath (VWR ultrasonic cleaner, VWR International, Radnor, PA, USA) before measurement.
4.5. Bis-ANS Binding
The relative fluorescence spectra of 4,4-bis-1-anilinonaphthalene-8-sufonate (Bis-ANS, Sigma
Aldrich, Merck KGaA, Darmstadt, Germany) were obtained using a Cary Eclipse spectrofluorometer
(Varian, Palo Alto, CA, USA). Spectra were recorded as the accumulation of three consecutive scans
and the conditions of the acquisition were: excitation wavelength of 370 nm, emission range from
400 to 700 nm, and slit widths of 5 nm; the measurements were performed at 25 ◦C in PBS buffer at
pH 7.4. The samples were sonicated for 10 min in an ultrasonic bath (VWR ultrasonic cleaner) before
dye addition. Prior to fluorescence measurements samples were incubated at room temperature for
5 min in the presence of a final Bis-ANS concentration 10 µM. A Bis-ANS solution without peptide
was used as a control.
4.6. Attenuated Total Reflectance (ATR) Fourier Transform Infrared (FTIR) Spectroscopy
Attenuated total reflectance Fourier transform infrared (ATR FT-IR) spectroscopy analysis of
peptide fibrils was performed using a Bruker Tensor FT-IR Spectrometer (Bruker Optics, Berlin,
Germany) with a Golden Gate MKII ATR accessory. Aggregated peptide solution, previously sonicated
for 10 min in an ultrasonic bath (VWR ultrasonic cleaner), was dried out under a N2 (g) atmosphere
and each spectrum consisted of 16 independent scans, measured at spectral resolution of 2 cm−1 within
the 1800–1500 cm−1 range. Spectral data were acquired and normalized using the OPUS MIR Tensor
27 software. The individual components of the spectrum were determined through second derivative
analysis of the spectra and deconvoluted afterwards into overlapping Gaussian curves. The amplitude,
mass center, bandwidth at half of the maximum amplitude, and area for each Gaussian function were
calculated employing the nonlinear peak-fitting program PeakFit v4.12 (Systat Software Inc., San Jose,
CA, USA). The PBS pH 7.4 buffer without peptide was used as a control and subtracted from the
absorbance signal before deconvolution.
4.7. Binding to Amyloid Dyes
Congo red binding (CR) to aggregated peptide solutions was determined using a Cary 100 UV/Vis
spectrophotometer (Varian, Palo Alto, CA, USA) in the 400–700 nm range using a 1 cm optical length
quartz cuvette placed in a thermostated cell holder at 25 ◦C.
The samples were sonicated for 10 min in an ultrasonic bath (VWR ultrasonic cleaner) before dye
addition. Prior to absorbance measurements samples were incubated at room temperature for 10 min
in the presence of 5 µM final CR concentration. PBS pH 7.4 buffer with 5 µM CR and without peptide
was used as a control.
The relative fluorescence spectra of Thioflavin-T (ThT, Sigma Aldrich, Merck KGaA, Darmstadt,
Germany) were monitored using a Cary Eclipse spectrofluorometer (Varian, Palo Alto, CA, USA).
Spectra were recorded as the accumulation of three consecutive scans and the conditions of the
acquisition were: excitation wavelength of 440 nm, emission range from 460 to 600 nm, and slit widths
of 5 nm; the measurements were performed at 25 ◦C in PBS buffer at pH 7.4. The samples were
sonicated for 10 min in an ultrasonic bath (VWR ultrasonic cleaner) before dye addition. Prior to
fluorescence measurements, samples were incubated at room temperature for 2 min in the presence of
a 25 µM final ThT concentration to ensure that thermal equilibrium had been achieved. PBS buffer at
pH 7.4 with 25 µM ThT and without peptide was used as a control.
For the Thioflavin-S (ThS, Sigma Aldrich, Merck KGaA, Darmstadt, Germany) staining by
fluorescence microscopy, Hsf1 aggregates were incubated for 1 h at room temperature with continuous
agitation at 80 rpm in the presence of ThS at a final concentration of 150 µM in PBS buffer at pH 7.4.
Then, the excess of ThS was washed up by centrifugation and resuspension of the precipitated fraction
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in PBS buffer at pH 7.4 three times. Finally, the precipitated fraction was resuspended in a final volume
of 10 µl, placed on a microscope slide, and the coverslip sealed. Images of the peptide aggregates
bound to ThS were obtained at 40-fold magnification under UV light or using phase contrast in a Leica
fluorescence microscope (Leica DMRB, Heidelberg, Germany).
4.8. Transmission Electron Microscopy (TEM)
An aliquot (5 µL) of 100 µM peptide incubated for 120 h at 25 ◦C and sonicated for 10 min in an
ultrasonic bath (VWR ultrasonic cleaner) was placed on carbon-coated copper grids and allowed to
absorb for 5 min. Then, the excess of solution was wicked away using small pieces of ashless filter
paper; the samples were stained with 5 µL of uranyl acetate (2% w/v) for 2 min for the negative
staining. Finally, the excess of uranyl acetate was removed as above, and the grids left to dry before the
TEM observation. Amyloid fibrils images were obtained using a JEOL JEM-1400 electron microscope,
(JEOL Peabody, MA, USA) operated at an 80-kV accelerating voltage.
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